Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
UBS Group
UBS
|
+$813M |
| 2 |
Alcon
ALC
|
+$368M |
| 3 |
Stellantis
STLA
|
+$301M |
| 4 |
Ferrovial SE
FER
|
+$289M |
| 5 |
CRH
CRH
|
+$267M |
Top Sells
| 1 |
Apple
AAPL
|
+$818M |
| 2 |
Microsoft
MSFT
|
+$412M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$394M |
| 4 |
Amazon
AMZN
|
+$234M |
| 5 |
GE Aerospace
GE
|
+$228M |
Sector Composition
| 1 | Technology | 32.51% |
| 2 | Financials | 12.19% |
| 3 | Healthcare | 11.56% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
THRD
3001
DELISTED
Third Harmonic Bio
THRD
| $20.8K | ﹤0.01% |
1,607
| – | – |
|
3002
Sutro Biopharma
STRO
$77.2M
| $20.7K | ﹤0.01% |
7,073
+2,113
| +43% | +$6.19K |
|
3003
Intrepid Potash
IPI
$392M
| $20.7K | ﹤0.01% |
884
| – | – |
|
3004
Citizens Financial Services
CZFS
$299M
| $20.6K | ﹤0.01% |
464
+112
| +32% | +$4.98K |
|
|
ILPT
3005
Industrial Logistics Properties Trust
ILPT
$415M
| $20.5K | ﹤0.01% |
+5,594
| New | +$20.5K |
|
3006
Bioventus
BVS
$468M
| $20.5K | ﹤0.01% |
+3,561
| New | +$20.5K |
|
3007
BARK
BARK
$147M
| $20.3K | ﹤0.01% |
11,206
| – | – |
|
3008
Medifast
MED
$152M
| $20.3K | ﹤0.01% |
929
-31,182
| -97% | -$680K |
|
3009
The Joint Corp
JYNT
$157M
| $20.2K | ﹤0.01% |
1,440
| – | – |
|
3010
Xoma
XOMA
$442M
| $20.2K | ﹤0.01% |
852
+321
| +60% | +$7.61K |
|
3011
James River Group
JRVR
$246M
| $20.1K | ﹤0.01% |
2,602
-32,109
| -93% | -$248K |
|
3012
Microvision
MVIS
$334M
| $20.1K | ﹤0.01% |
18,963
-145,808
| -88% | -$155K |
|
3013
Willis Lease Finance
WLFC
$1.13B
| $20.1K | ﹤0.01% |
290
+67
| +30% | +$4.64K |
|
|
PHLT
3014
Performant Healthcare, Inc. Common Stock
PHLT
$604M
| $20.1K | ﹤0.01% |
6,919
-29
| -0.4% | -$84 |
|
3015
American Vanguard Corp
AVD
$152M
| $20K | ﹤0.01% |
2,331
-719
| -24% | -$6.18K |
|
3016
Atea Pharmaceuticals
AVIR
$250M
| $20K | ﹤0.01% |
6,044
| – | – |
|
3017
BayCom
BCML
$329M
| $19.9K | ﹤0.01% |
979
| – | – |
|
3018
Regional Management Corp
RM
$412M
| $19.9K | ﹤0.01% |
693
| – | – |
|
3019
ReposiTrak
TRAK
$306M
| $19.7K | ﹤0.01% |
+1,292
| New | +$19.7K |
|
3020
Natural Gas Services Group
NGS
$333M
| $19.7K | ﹤0.01% |
+976
| New | +$19.7K |
|
3021
Utah Medical Products
UTMD
$195M
| $19.7K | ﹤0.01% |
295
-320
| -52% | -$21.4K |
|
3022
AngioDynamics
ANGO
$445M
| $19.7K | ﹤0.01% |
3,255
| – | – |
|
3023
Hyliion Holdings
HYLN
$288M
| $19.7K | ﹤0.01% |
12,132
| – | – |
|
3024
Northeast Community Bancorp
NECB
$272M
| $19.6K | ﹤0.01% |
1,102
| – | – |
|
3025
Maui Land & Pineapple Co
MLP
$337M
| $19.6K | ﹤0.01% |
890
-7
| -0.8% | -$154 |
|